Skip to main content
Caplight Logo









BioTuring

BioTuring

Private
San Diego, CaliforniaHealthcare & Life Scienceshttps://bioturing.com

Company Overview

BioTuring operates in Healthcare & Life Sciences and is based in San Diego, California. It was founded in 2016.

BioTuring is a bioinformatics company that develops algorithms and agentic AI software to enable scientists to analyze and visualize single-cell and spatial biology data.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Healthcare Analytics, Drug Discovery, Data Visualization

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

BioTuring Comparables

Compare BioTuring with similar companies based on industry and business-model similarity.

BioTuring comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
BigOmics Analytics
84%
Rosalind
83%
Pluto Biosciences
82%
Book a demo to see all comparables

For institutional investors. Book with your work email.

BioTuring Funding Rounds

Historical fundraising activity

Funding history

No completed funding rounds are published for BioTuring. Book a demo to ask about coverage.

Book a demo

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Son Pham

CEO and Chief Scientist, Chief Scientist

Executive Team

For institutional investors. Book with your work email.

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 20, 2026

    Monthly visitors increased 83% MoM.

  • Sep 4, 2025

    Grew 19% QoQ, from 54 to 64 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

BioTuring Filings

Explore SEC and related filing metadata, where available.

BioTuring filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about BioTuring's valuation, stock price, and market status.

Is BioTuring a public or private company?

BioTuring is a private company.

What is the current stock price of BioTuring?

BioTuring is a private company, so its shares have no public market price. Caplight tracks BioTuring's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is BioTuring worth (valuation)?

Valuation information for BioTuring is not publicly available.

Can I buy BioTuring stock?

BioTuring shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was BioTuring's last funding round?

Funding round information for BioTuring is not publicly available.

Who are the main investors in BioTuring?

Investor information for BioTuring is not publicly disclosed.

Will BioTuring IPO soon?

No public IPO plans have been announced for BioTuring.

How can I track BioTuring secondary market activity?

Caplight tracks bids, offers, and trades in BioTuring's shares on secondary markets.

Firmographic Details

HeadquartersSan Diego, California
Employee Range55
Year Founded2016
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?